Last checked at 21 Sep 2020 16:24
IN BRIEF: MaxCyte Interim Revenue Jumps And Loss Narrows
IN BRIEF: MaxCyte Interim Revenue Jumps And Loss Narrows
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MaxCyte Share News (MXCT)
MXCT Share
Price
MXCT Share
News
MXCT Share
Chat
MXCT Share
Trades5
MXCT
Live RNS
MXCT Share
Charts
MXCT Level 2
Console
MXCT Live
Share Price
MXCT Broker
Ratings
MXCT Directors
Deals
MXCT Financial
Diary
MXCT
Fundamentals
MXCT Short
Positions
MXCT
Media
MaxCyte Information
Share Price Information for MaxCyte (MXCT)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
297.00
Bid:
290.00
Ask:
304.00
Change:
2.00 (0.68%)
Spread:
14.00 (4.828%)
Open:
295.00
High:
297.00
Low:
290.00
Prev. Close:
295.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.14 Sep 2020 15:44
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more9 Sep 2020 14:28
MaxCyte Hires Murphy As Finance Chief; Holtz Becomes Accounting Boss
MaxCyte Hires Murphy As Finance Chief; Holtz Becomes Accounting Boss
Read more9 Sep 2020 09:35
MaxCyte appoints Amanda Murphy as CFO
(Sharecast News) - Life sciences company MaxCyte named Amanda Murphy as its chief financial officer on Wednesday, succeeding long-time CFO Ron Holtz.
Read more18 Aug 2020 20:04
IN BRIEF: MaxCyte Says CARMA's Phase 1 MCY-M11 Trial Expanded
IN BRIEF: MaxCyte Says CARMA's Phase 1 MCY-M11 Trial Expanded
Read more15 Jul 2020 13:31
MaxCyte Sees Higher Interim Revenue, Confident On Long-Term Prospects
MaxCyte Sees Higher Interim Revenue, Confident On Long-Term Prospects
Read more8 Jul 2020 15:51
IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics
IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics
Read more7 May 2020 17:30
UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service
UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service
Read more1 May 2020 08:54
MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO
MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO
Read more21 Apr 2020 16:59
MaxCyte Annual Loss Widens As Carma Investment Increases
MaxCyte Annual Loss Widens As Carma Investment Increases
Read more9 Apr 2020 14:54
UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost
UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost
Read more21 Feb 2020 11:53
MaxCyte to consolidate stock to single trading line
(Sharecast News) - Life sciences company MaxCyte announced the consolidation of its two lines of common stock into a single unrestricted line of common stock on Friday.
Read more20 Jan 2020 10:58
MaxCyte 'exceptionally positive' following strong FY trading performance
(Sharecast News) - Clinical-stage life sciences company MaxCyte told investors on Monday that its board was "exceptionally positive" of the group's future following a stellar year.
Read more20 Jan 2020 09:00
MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue
MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue
Read more4 Dec 2019 16:14
MaxCyte inks new development agreement with KSQ Therapeutics
(Sharecast News) - Cell-based therapeutics and life sciences company MaxCyte has entered into a new development and commercialisation agreement with its existing partner KSQ Therapeutics, it announced on Wednesday.
Read more